OQROGet OQRO Pro
Insider trade

Edwards Lifesciences (EW)Officer sold ~$20K

Wayne Markowitz, Officer at Edwards Lifesciences, sold ~$20K of Edwards Lifesciences shares.

~$20K
Approx. value · 268 sh @ $75.08
9,299.19
Holds after · shares reported
Traded
May 7, 2025
Filed
May 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
  2. Mar 10, 2025Insider · 2 peopleInsiders: 2 sales (~$456K)
  3. Mar 13, 2025InsiderOfficer sold ~$646K of EW shares in the open market
  4. Mar 21, 2025FDAFDA device clearance: FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors
  5. Mar 26, 2025InsiderCFO sold ~$797K of EW shares in the open market
  6. Mar 27, 2025FDAFDA device clearance: Edwards eSheath Optima introducer set
  7. Apr 7, 2025CongressDisclosed purchase of EW — reported range $15,001 - $50,000
  8. Apr 8, 2025InsiderOfficer sold ~$21K of EW shares in the open market
  9. Apr 8, 2025CongressDisclosed purchase of EW — reported range $1,001 - $15,000
  10. Apr 14, 2025InsiderOfficer sold ~$663K of EW shares in the open market
  11. Apr 21, 2025CongressDisclosed sale of EW — reported range $1,001 - $15,000
  12. May 5, 2025InsiderCEO sold ~$448K of EW shares in the open market
  13. May 7, 2025 · this disclosureInsiderOfficer sold ~$20K of EW shares in the open market

What came next

  1. May 9, 2025Insider · 2 peopleInsiders: 2 sales (~$862K)
  2. May 12, 2025CongressDisclosed sale of EW — reported range $50,001 - $100,000
  3. May 14, 2025FDARecall: Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software Version: N/A Product Description: Cardiac c…
  4. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS Software Version: N/A Product Description: The Edwards FEMFLEXI…
  5. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII018A Software Version: N/A Product Description: The Edwards FEMFLEXII…
  6. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016A Software Version: N/A Product Description: The Edwards FEMFLEXII…
  7. May 14, 2025FDARecall: Brand Name: FEM-FLEXII Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII018AS Software Version: N/A Product Description: The Edwards FEMFLEXII…
  8. May 14, 2025FDARecall: Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI18 Software Version: N/A Product Description: Cardiac c…
  9. May 15, 2025FDAFDA device clearance: Hypertension Prediction Index (HePI) Algorithm
  10. May 22, 2025InsiderOfficer sold ~$113K of EW shares in the open market
  11. May 30, 2025InsiderCEO sold ~$1.24M of EW shares in the open market
  12. Jun 2, 2025InsiderOfficer sold ~$199K of EW shares in the open market
  13. Jun 3, 2025InsiderCEO sold ~$75K of EW shares in the open market
  14. Jun 16, 2025InsiderOfficer sold ~$673K of EW shares in the open market
  15. Jul 23, 2025FDAFDA device clearance: HemoSphere Advanced Monitor (HEM1); HemoSphere Technology Module (HEMTOM10); HemoSphere ClearSight Module (HEMCSM10); Smart Pressure Controller (PC1Q); Acumen…
  16. Jul 28, 2025InsiderOfficer sold ~$327K of EW shares in the open market
  17. Aug 18, 2025InsiderOfficer sold ~$699K of EW shares in the open market
  18. Aug 25, 2025InsiderOfficer sold ~$205K of EW shares in the open market
  19. Aug 29, 2025FDAFDA device clearance: Edwards eSheath Optima introducer set
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 11 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 21 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

Other recent filings by Wayne Markowitz, GM & SVP, Surgical

The full history of Wayne Markowitz, GM & SVP, Surgical is on the profile page.

How this filing works

Other disclosures at Edwards Lifesciences

Everything OQRO holds on this company is on its EW page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data